Self Efficacy, Walking Ability, Gait Speed and Physical Activity in People With Chronic Lung Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

70 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-12-31

Study Completion Date

2012-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Most patients with chronic lung disease underestimate their actual walking ability due to low confidence. To better understand the relationships between lung function, self-efficacy for walking (confidence in ability to walk a defined distance), actual walking ability for the same distance gait speed and physical activity level-PAL- (total energy expenditure/resting metabolic rate).

Quality of life, self efficacy for activity questionnaires, physical activity level measurement, 4-meter gait speed and 6-minute walk distance will be measured.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Physical Activity and Self-Efficacy After Pulmonary Rehabilitation

NCT02086383

Chronic Obstructive Pulmonary Disease

UNKNOWN

Impact of Feedback on Physical Activity and Health-related Outcomes During Pulmonary Rehabilitation in COPD

NCT02725931

Pulmonary Disease, Chronic Obstructive

COMPLETED NA

Lifestyle Physical Activity for People With COPD

NCT01856231

COPD

COMPLETED NA

Walking Speeds in Patients With Chronic Obstructive Pulmonary Disease

NCT01768754

Chronic Obstructive Pulmonary Disease

COMPLETED

Physical Activity Coaching in Chronic Obstructive Pulmonary Disease (COPD)

NCT01349608

Chronic Obstructive Pulmonary Disease Physical Activity Health Behavior

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Lung Disease Self-efficacy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Men and women 40 years and older
* Diagnosis of any chronic lung disease as evidenced by pulmonary function testing completed within the prior 12 months
* Able to walk independently and successfully complete the 6-minute walk assessment

Exclusion Criteria

* Unable to walk without assistance or complete the 6-minute walk assessment
* Patients unable to comprehend and accurately respond to the study questionnaires either by written or spoken communication
* Patients diagnosed with or treated for a lower respiratory tract infection or COPD exacerbation within the prior 30 days

Minimum Eligible Age

40 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No